Predictors of psychological distress among individuals with a strong family history of malignant melanoma

Clinical Genetics

Volumn 73, Issue 2, 2008, Pages 121-131

  Kasparian, Nadine A ^a,b   Meiser, B ^a,b   Butow, P N ^c   Simpson, J M ^d   Mann, G J ^e  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c School of Psychology   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anxiety; Causal attributions; Depression; Family history; Melanoma; Psychological adjustment

Indexed keywords

ADOLESCENT; ADULT; ANXIETY; ARTICLE; COHORT ANALYSIS; DEPRESSION; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MELANOMA; MENTAL STRESS; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RISK; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; ANXIETY; COHORT STUDIES; DEPRESSION; FAMILY HEALTH; FEMALE; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; STRESS, PSYCHOLOGICAL;

EID: 38349095097     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00949.x     Document Type: Article

References (80)

1. Aitken JF, Duffy DL, Green A et al. Heterogeneity of melanoma risk in families of melanoma patients. Am J Epidemiol 1994: 140: 961-973.
2. Goldstein A, Chan M, Harland M et al. Assessment of high-risk melanoma susceptibility genes and their associations with pancreatic cancer, neural system tumors, and uveal melanoma: a Melanoma Genetics Consortium (GenoMEL) study. Cancer Res 2006: 66: 9818-9828.
3. Hayward N. Genetics of melanoma predisposition. Oncogene 2003: 22: 3053-3062.
4. Tucker M, Goldstein A. Melanoma etiology: where are we? Oncogene 2003: 22: 3042-3052.
5. Bishop D, Demenais F, Goldstein A et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002: 94: 894-903.
6. Kefford R, Newton-Bishop J, Bergman W et al. Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a Consensus Statement of the Melanoma Genetics Consortium. J Clin Oncol 1999: 17: 3245-3251.
7. Parkin D, Bray F, Ferlay J et al. Global cancer statistics 2002. CA Cancer J Clin 2005: 55: 74-108.
8. McGuire D. Impact of hereditary melanoma on families. Cancer Nurs 1984: 7: 451-459.
9. Brandberg Y, Bergenmar M, Bolund C et al. Psychological effects of participation in a prevention programme for individuals with increased risk for malignant melanoma. Eur J Cancer 1992: 28A: 1334-1338.
10. Brandberg Y, Bolund C, Sigurdardottir V et al. Anxiety and depressive symptoms at different stages of malignant melanoma. PsychoOncology 1992: 1: 71-78.
11. Riedijk S, de Snoo F, van Dijk S et al. Hereditary melanoma and predictive genetic testing: why not? Psycho- Oncology 2005: 14: 738-745.
12. Thewes B, Meiser B, Tucker K et al. Screening for psychological distress in women at increased risk for breast cancer: a review of the literature. Psychol Health Med 2003: 8: 289-304.
13. Meiser B, Collins V, Warren R et al. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 2004: 66: 502-511.
14. Meiser B, Butow P, Schnieden V et al. Psychological character- istics of women at increased risk of developing hereditary breast cancer. Psychol Health Med 2000: 5: 377-388.
15. van Roosmalen MS, Stalmeier PF, Verhoef LC et al. Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. Am J Med Genet 2004: 124A: 346-355.
16. Watson M, Lloyd S, Davidson J et al. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer 1999: 79: 868-874.
17. Lodder L, Frets P, Trijsburg R et al. Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 2001: 98: 15-24.
18. Goodwin RD, Gotlib IH. Gender differences in depression: the role of personality factors. Psychiatry Res 2004: 126: 135-142.
19. DudokdeWit A, Duivenvoorden H, Passchier J et al. Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing programme: an exploratory study. Psychosom Med 1998: 60: 543-549.
20. DudokdeWit AC, Tibben A, Duivenvoorden HJ et al. Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? J Med Genet 1998: 35: 745-754.
21. Lodder L, Frets P, Trijsburg R et al. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? J Med Genet 1999: 36: 906-913.
22. Wellisch D, Lindberg N. A psychological profile of depressed and nondepressed women at high risk for breast cancer. Psychosomatics 2001: 42: 330-336.
23. Baider L, Ever-Hadani P, De-Nour A. Psychological distress in healthy women with familial breast cancer: like mother, like daughter? Int J Psychiatry Med 1999: 29: 411-420.
24. Julian-Reynier C, Eisinger F, Chabal F et al. Cancer genetic consultation and anxiety in healthy consultees. Psychol Health 1999: 14: 379-390.
25. van Oostrom I, Meijers-Heijboer H, Lodder L et al. Long- term psychological impact of carrying a BRCA1/2 muta- tion and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 2003: 21: 3867-3874.
26. Miller S, Shoda Y, Hurley K. Applying cognitive-social theory to health protective behavior: breast self-examination in cancer screening. Psychol Bull 1996: 119: 70-94.
27. Miller S, Fang C, Diefenbach M et al. Tailoring psychosocial interventions to the individual's health information-processing style: the influence of monitoring versus blunting in cancer risk and disease. In: Baum A, Andersen B., eds. Psychosocial interventions for cancer. Washington, DC: American Psychological Society, 2001: 343-362.
28. Holland E, Schmid H, Kefford R et al. CDKN2A (p16INK4a) and CDK4 mutation analysis in 131 Austra- lian melanoma probands: effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 1999: 25: 339-348.
29. Kasparian N, Meiser B, Butow P et al. Better the devil you know? High-risk individuals' anticipated psychological responses to genetic testing for melanoma susceptibility. J Genet Counsel 2006: 15: 433-447.
30. Kasparian N, Butow P, Meiser B et al. High- and average- risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective. Psycho- oncology (in press). doi: 10.1002/pon.1230
31. Kasparian N, Meiser B, Butow P et al. Anticipated uptake of genetic testing for familial melanomainanAustraliansample: An exploratory study. Psycho-oncology 2007: 16: 69-78.
32. Cella D, Hughes C, Peterman A et al. A brief assessment of concerns associated with genetic testing for cancer: The Multidimensional Impact of Cancer Risk Assessment (MICRA) Questionnaire. Health Psychol 2002: 21: 564-572.
33. Miller S, Daly M, Sherman K et al. Psychosocial processes in genetic risk assessment for breast cancer. In: Miller S, McDaniel S, Rolland J, Feetham S, eds. Individuals, families, and the new era of genetics. New York: WW Norton, 2006: 274-319.
34. Miller SM, Diefenbach MA. The cognitive-social health information-processing (C-SHIP) model: a theoretical framework for research in behavioral oncology. In: Krantz D, Baum A, eds. Technology and methods in behavioral medicine. Mahwah, NJ: Lawrence Erlbaum Associates, 1998: 219-244.
35. Miller S. Monitoring and blunting: validation of a ques- tionnaire to assess styles of information seeking under threat. J Pers Soc Psychol 1987: 52: 345-353.
36. Miller SM. Monitoring and blunting of threatening infor- mation: cognitive interference and facilitation in the coping process. In: Sarason I, Pierce G, Sarason B, eds. Cognitive interference: theories, methods, and findings. Hillsdale, NJ: Lawrence Erlbaum Associates, 1996: 175-190.
37. Miller S, Roussi P, Altman D et al. Effects of coping style on psychological reactions of low-income, minority women to colposcopy. J Reprod Med 1994: 39: 711-718.
38. Muris P, Schouten E. Monitoring and blunting: a factor analysis of the Miller Behavioural Style Scale. Pers Individ Dif 1994: 17: 285-287.
39. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979: 41: 209-218.
40. Cella D, Mahon SM, Donovan M. Cancer recurrence as a traumatic event. Behav Med 1990: 16: 15-22.
41. Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983: 67: 361-370.
42. Hosmer DW, Lemeshow S. Applied logistic regression. Toronto: Wiley & Sons, Inc, 2000.
43. Kleinbaum D, Kupper L, Muller K. Applied regression analysis and other multivariate methods. Boston, MA: PWS-KENT, 1987.
44. Liang K, Zeger S. Longitudinal data analysis using generalised linear models. Biometrika 1986: 73: 13-22.
45. Crawford J, Henry J, Crombie C et al. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 2001: 40: 429-434.
46. DudokdeWit A, Tibben A, Duivenvoorden H et al. Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. J Med Genet 1997: 34: 382-390.
47. Lerman C, Schwartz M, Narod S et al. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997: 65: 414-420.
48. Butow P, Meiser B, Price M et al. Psychological morbidity in women at increased risk of developing breast cancer: a controlled study. The Kathleen Cuningham Consortium for Research into Familial Breast Cancer Psychosocial Group. Psychooncology 2005: 14: 196-203.
49. Kash KM, Ortega-Verdejo K, Dabney MK et al. Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer. Semin Surg Oncol 2000: 18: 333-338.
50. Thirlaway K, Fallowfield L, Nunnerley H et al. Anxiety in women 'at risk' of developing breast cancer. Br J Cancer 1996: 73: 1422-1424.
51. Meiser B, Butow P, Price M et al. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer. J Womens Health 2003: 12: 769-778.
52. Tibben A, Timman R, Bannink E et al. Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychol 1997: 16: 20-35.
53. Kessler S, Bloch M. Social system responses to Huntington disease. Fam Process 1989: 28: 59-68.
54. Pasacreta J. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Cancer Invest 2003: 21: 588-623.
55. Hill D, Marks R, Borland R. Changes in sun-related attitudes and behaviors, and reduced sunburn prevalence in a population at high risk of melanoma. In: Hornik R, ed. Public health communication: evidence for behavior change. Mahwah, NJ: Lawrence Erlbaum Associates, 2002: 163-180.
56. Montague M, Borland R, Sinclair C.Slip! Slop! Slap! and SunSmart. 1980-2000: skin cancer control and 20 years of population-based campaigning. Health Educ Behav 2001; 28:290-305.
57. Kash KM, Holland JC, Halper MS et al. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992; 84:24-30.
58. Meiser B, Butow P, Barratt A et al. Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. Breast Cancer Res Treat 2000; 59:101-111.
59. Lerman C, Daly M, Sands C et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993; 85:1074-1080.
60. Ritvo P, Robinson G, Irvine J et al. A longitudinal study of psychological adjustment to familial genetic risk assessment for ovarian cancer. Gynecol Oncol 1999; 74:331-337.
61. Hallowell N, Ardern-Jones A, Eeles R et al. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clin Genet 2005; 67:492-502.
62. Claes E, Evers-Kiebooms G, Boogaerts A et al. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet 2003: 116A: 11-19.
63. Erblich J, Bovbjerg D, Valdimarsdottir H. Looking forward and back: distress among women at familial risk for breast cancer. Ann Behav Med 2000; 22:53-59.
64. Kent G, Howie H, Fletcher M et al. The relationship between perceived risk, thought intrusiveness and emotional well-being in women receiving counselling for breast cancer risk in a family history clinic. Br J Health Psychol 2000; 5:15-26.
65. Lloyd S, Watson M, Waites B et al. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer 1996; 74:482-487.
66. Zakowski SG, Valdimarsdottir HB, Bovbjerg DH et al. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med 1997; 19:362-369.
67. Audrain J, Schwartz M, Lerman C et al. Psychological distress in women seeking genetic counseling for breast- ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med 1997; 19:370-377.
68. Cull A, Anderson E, Campbell S et al. The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. Br J Cancer 1999; 79:501-508.
69. Hopwood P, Keeling F, Long A et al. Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psycho-oncology 1998; 7:402-412.
70. McDonough P, Walters V. Gender and health: reassessing patterns and explanations. Soc Sci Med 2001; 52:547-559.
71. Branstrom R, Ullen H, Brandberg Y. Attitudes, subjective norms and perception of behavioural control as predictors of sun-related behaviour in Swedish adults. Prev Med 2004; 39:992-999.
72. Meiser B, Butow P, Schnieden V et al. Psychological adjustment of women at increased risk of developing hereditary breast cancer. Psychol Health Med 2000; 5:377-388.
73. van Dooren S, Rijnsburger A, Seynaeve C et al. Psychological distress in women at increased risk for breast cancer: the role of risk perception. Eur J Cancer 2004; 40:2056-2063.
74. Rolland J, Williams . Toward a biopsychosocial model for 21st century genetics. Fam Process 2005; 44:3-24.
75. Daly M, Farmer J, Harrop-Stein C et al. Exploring family relationships in cancer risk counseling using the genogram. Cancer Epidemiol Biomarkers Prev 1999; 8:393-398.
76. Audrain J, Rimer B, Cella D et al. The impact of a brief coping skills intervention on adherence to breast self- examination among first-degree relatives of newly diagnosed breast cancer patients. Psycho-oncology 1999; 8:220-229.
77. Fawzy FI, Kemeny ME, Fawzy NW et al. A structured psychiatric intervention for cancer patients: I. Changes over time and methods of coping in affect of disturbance. Arch Gen Psychiatry 1990; 47:720-725.
78. Boesen EH, Ross L, Frederiksen K et al. Psychoeduca- tional intervention for patients with cutaneous malignant melanoma: a replication study. J Clin Oncol 2005; 23:1270-1277.
79. McInerney-Leo A, Biesecker B, Hadley D et al. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. Am J Med Genet 2004: 130A: 221-227.
80. Schwartz M, Lerman C, Rimer B. Psychosocial interventions for women at increased risk for breast cancer. In: Baum A, Andersen B, eds. Psychosocial interventions for cancer. Washington, DC: American Psychological Society, 2001: 287-304.